Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range
返回论文页
|更新时间:2023-04-28
|
Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range
Yu Jing, He Lei, Palati·Reheman, et al. Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range. [J]. 29(4):7-10(2023)
DOI:
Yu Jing, He Lei, Palati·Reheman, et al. Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range. [J]. 29(4):7-10(2023) DOI: 10.13407/j.cnki.jpp.1672-108X.2023.04.002.
Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiangand Preliminary Establishment of Reference Range
Objective: To explore the factors affecting the steady-state plasma concentration of lacosamide (LCM) in children with epilepsy in Xinjiang
and to establish the reference range of steady-state plasma concentration of LCM
so as to provide theoretical basis for clinical individualized drug use. Methods: The serum drug concentration was collected and measured in 313 children with epilepsy in Xinjiang who regularly took LCM and reached steady-state blood concentration
and the effects of age
gender
ethnicity
dosage and combined use on the serum concentration of LCM were analyzed
and the reference range of steady-state serum concentration of LCM was preliminarily established. Results: There was no significant difference in LCM concentration-dose ratio (CDR) values among children with epilepsy of different genders and ethnic groups (P>0. 05). The dosage of the 4 to 6 age group was significantly higher than that of the 7 to 14 age group
and the CDR results of the 7 to 14 age group were significantly higher than that of the 4 to 6 age group (all P< 0. 01). The concentration results of the children in the LCM single drug group were significantly lower than those of the LCM combined with other antiepileptic drugs groups (all P<0. 05). The reference range of steady-state blood concentration of LCM in this study was 2. 02-14. 47 μg/ mL. Conclusion: During the clinical use of LCM to control and treat epilepsy in children
it is necessary to monitor the therapeutic drug of LCM in order to adjust its dosage in time and better control epileptic seizures.
关键词
癫痫儿童拉考沙胺血药浓度参考范围
Keywords
epilepsychildrenlacosamideplasma concentrationreference range